The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: A tissue microarray study

Pathology Research and Practice

Volumn 210, Issue 7, 2014, Pages 412-418

  Baspinar, Sirin ^a   Bircan, Sema ^a   Orhan, Hikmet ^a   Kapucuoglu, Nilgun ^a   Bozkurt, Kemal Kursat ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Bcl 2; Beclin 1; High grade prostatic intraepithelial neoplasia; Prostate adenocarcinoma

Indexed keywords

BECLIN 1; PROTEIN BCL 2; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PROSTATE ADENOCARCINOMA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TISSUE MICROARRAY; TUMOR INVASION; UPREGULATION; ADENOCARCINOMA; AGED; BIOSYNTHESIS; DISEASE COURSE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTATE HYPERTROPHY; PROSTATE TUMOR; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM GRADING; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84901480699     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2014.02.008     Document Type: Article

References (42)

1. Bostwick D.G., Meiers I. Neoplasms of the prostate. Urologic Surgical Pathology 2008, 444-578. Mosby-Elsevier, Missouri. 2nd ed. D.G. Bostwick, L. Cheng (Eds.).
2. Eble J.N., Sauter G., Epstein J.I., Sesterhenn I.A. World Health Organization classification of tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs 2004, 160-215. IARC Press, Lyon.
3. Han M., Partin A.W., Pound C.R., Epstein J.I., Walsh P.C. Longterm biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol. Clin. North Am. 2001, 28:555-565.
4. Levine B., Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 2004, 6:463-477.
5. Zhou F., Yang Y., Xing D. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J. 2011, 278:403-413.
6. Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin. Nature 1999, 402:672-676.
7. Wang C.W., Klionsky D.J. The molecular mechanism of autophagy. Mol. Med. 2003, 9:65-76.
8. Shintani T., Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 2004, 306:990-995.
9. Li Z., Chen B., Wu Y., Jin F., Xia Y., Liu X. Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors. BMC Cancer 2010, 10:98.
10. Eskelinen E.L. The dual role of autophagy in cancer. Curr. Opin. Pharmacol. 2011, 11:294-300.
11. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., Packer M., Schneider M.D., Levine B. Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell 2005, 122:927-939.
12. Lin Y., Fukuchi J., Hiipakka R.A., Kokontis J.M., Xiang J. Up-regulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stage. Cell Res. 2007, 17:531-536.
13. Catz S.D., Johnson J.L. BCL-2 in prostate cancer: a minireview. Apoptosis 2003, 8:29-37.
14. Chen Y., Lu Y., Lu C., Zhang L. Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression. Pathol. Oncol. Res. 2009, 15:487-493.
15. Miracco C., Cosci E., Oliveri G., Luzi P., Pacenti L., Monciatti I., Mannucci S., De Nisi M.C., Toscano M., Malagnino V., Falzarano S.M., Pirtoli L., Tosi P. Protein and mRNA expression of autophagy gene beclin in human brain tumours. Int. J. Oncol. 2007, 30:429-436.
16. Shen Y., Li D.D., Wang L.L., Deng R., Zhu X.F. Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. Autophagy 2008, 4:1067-1068.
17. Shi Y.H., Ding Z.B., Zhou J., Qiu S.J., Fan J. Prognostic significance of beclin 1-dependent apoptotic activity in hepatocellular carcinoma. Autophagy 2009, 5:380-382.
18. Won K.Y., Kim G.Y., Lim S.J., Kim Y.W. Decreased beclin-1 expression is correlated with the growth of the primary tumor in patients with squamous cell carcinoma and adenocarcinoma of the lung. Hum. Pathol. 2012, 43:62-68.
19. Ahn C.H., Jeong E.G., Lee J.W., Kim M.S., Kim S.H., Kim S.S., Yoo N.J., Lee S.H. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS 2007, 115:1344-1349.
20. Wan X.B., Fan X.J., Chen M.Y., Xiang J., Huang P.Y., Guo L., Wu X.Y., Xu J., Long Z.J., Zhao Y., Zhou W.H., Mai H.Q., Liu Q., Hong M.H. Elevated beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy 2010, 6:395-404.
21. Huang J.J., Li H.R., Huang Y., Jiang W.Q., Xu R.H., Huang H.Q., Lv Y., Xia Z.J., Zhu X.F., Lin T.Y., Li Z.M. Beclin 1 expression: a predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type. Autophagy 2010, 6:777-783.
22. Xu L.W., Qian M., Jia R.P., Xu Z., Wu J.P., Li W.C., Huang W.B., Chen X.G. Expression and significance of microsomal prostaglandin synthase-1 (mPGES-1) and beclin-1 in the development of prostate cancer. Asian Pac. J. Cancer Prev. 2012, 13:1639-1644.
23. Giatromanolaki A., Sivridis E., Mendrinos S., Koutsopoulos A.V., Koukourakis M.I. Autophagy proteins in prostate cancer: relation with anaerobic metabolism and Gleason score. Urol. Oncol. 2014, 32:e11-e18. 39.
24. Lian J., Karnak D., Xu L. The Bcl-2-beclin 1 interaction in (-)-gossypol-induced autophagy versus apoptosis in prostate cancer cells. Autophagy 2010, 6:1201-1203.
25. Bhutia S.K., Dash R., Das S.K., Azab B., Su Z.Z., Lee S.G., Grant S., Yacoub A., Dent P., Curiel D.T., Sarkar D., Fisher P.B. Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24. Cancer Res. 2010, 70:3667-3676.
26. Epstein J.I., Allsbrook W.C., Amin M.B., Egevad L.L. ISUP Grading Committee, The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am. J. Surg. Pathol. 2005, 29:1228-1242.
27. Sobin L.H., Wittekind C. TNM Classification of Malignant Tumours 2002, 184-187. Wiley-Liss, New York. 6th ed.
28. Baspinar S., Bircan S., Yavuz G., Kapucuoglu N. Beclin 1 and bcl-2 expressions in bladder urothelial tumors and their association with clinicopathological parameters. Pathol. Res. Pract. 2013, 209:418-423.
29. Furuya Y., Krajewski S., Epstein J.I., Reed J.C., Isaacs J.T. Expression of Bcl-2 and the progression of human and rodent prostatic cancers. Clin. Cancer Res. 1996, 2:389-398.
30. Martin A.P., Park M.A., Mitchell C., Walker T., Rahmani M., Thorburn A., Häussinger D., Reinehr R., Grant S., Dent P. BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing. Mol. Pharmacol. 2009, 76:327-341.
31. McDonnell T.J., Troncoso P., Brisbay S.M., Logothetis C., Chung L.W., Hsieh J.T., Tu S.M., Campbell M.L. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 1992, 52:6940-6944.
32. Bubendorf L., Sauter G., Moch H., Jordan P., Blöchlinger A., Gasser T.C., Mihatsch M.J. Prognostic significance of Bcl-2 in clinically localized prostate cancer. Am. J. Pathol. 1996, 148:1557-1565.
33. Anvari K., Seilanian Toussi M., Kalantari M., Naseri S., Karimi Shahri M., Ahmadnia H., Katebi M., Sedighi Pashaki A., Dayani M., Broumand M. Expression of Bcl-2 and Bax in advanced or metastatic prostate carcinoma. Urol. J. 2012, 9:381-388.
34. Mackey T.J., Borkowski A., Amin P., Jacobs S.C., Kyprianou N. Bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. Urology 1998, 52:1085-1090.
35. Zellweger T., Ninck C., Bloch M., Mirlacher M., Koivisto P.A., Helin H.J., Mihatsch M.J., Gasser T.C., Bubendorf L. Expression patterns of potential therapeutic targets in prostate cancer. Int. J. Cancer 2005, 113:619-628.
36. Stattin P., Damber J.E., Karlberg L., Nordgren H., Bergh A. Bcl-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia, grade, hormonal status, metastatic growth and survival. Urol. Res. 1996, 24:257-264.
37. Iacopino F., Angelucci C., Lama G., Zelano G., La Torre G., D'Addessi A., Giovannini C., Bertaccini A., Macaluso M.P., Martorana G., Sica G. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma. Anticancer Res. 2006, 26:1849-1854.
38. Hering F.L., Lipay M.V., Lipay M.A., Rodrigues P.R., Nesralah L.J., Srougi M. Comparison of positivity frequency of bcl-2 expression in prostate adenocarcinoma with low and high Gleason score. Sao Paulo Med. J. 2001, 119:138-141.
39. Aita V.M., Liang X.H., Murty V.V., Pincus D.L., Yu W., Cayanis E., Kalachikov S., Gilliam T.C., Levine B. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999, 59:59-65.
40. Yue Z., Jin S., Yang C., Levine A.J., Heintz N. Beclin an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:15077-15082.
41. Cao S.S., Su A.P., Du X.J., Li A., Hu W.M., Zhang Z.D., Tian B.L., Lu H.M., Ke N.W., He Z.P. The expressions and correlation of bcl-2 and Beclin-1 in pancreatic cancer. Sichuan Da Xue Xue Bao Yi Xue Ban 2012, 43:156-160.
42. Won K.Y., Kim G.Y., Kim Y.W., Song J.Y., Lim S.J. Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer. Hum. Pathol. 2010, 41:107-112.